Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Holdings, Inc.

CERE
Cerevel Therapeutics Holdings, Inc.US flagNASDAQ Capital Market
44.96
USD
+0.33
- -
8.19BMarket Cap

Income Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- Operating Expenses
83
149
220
368
447
+ Selling, General & Admin
33
46
58
88
113
+ Research & Development
50
103
162
280
335
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
-83
-149
-220
-368
-447
- Non-Operating (Income) Loss
45
3
5
-16
-15
+ Interest Expense, Net
-2
- -
- -
-10
-33
+ Interest Expense
- -
- -
- -
4
11
- Interest Income
2
- -
- -
14
44
+ Other Non-Op (Income) Loss
46
3
5
-7
18
Pretax Income
-128
-152
-225
-351
-432
- Income Tax Expense (Benefit)
- -
- -
- -
- -
1
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-128
-152
-225
-352
-433
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-128
-152
-225
-352
-433
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-128
-152
-225
-352
-433
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-128
-152
-225
-352
-433
EBIT
-83
-149
-220
-368
-447
EBITDA
-83
-149
-217
-363
-442
EBITDA Margin (%)
- -
- -
- -
- -
- -
EBITA
-83
-149
-220
-368
-447
Gross Margin (%)
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
3
5
6
Basic Weighted Avg Shares
127
74
137
151
- -
Basic EPS, GAAP
-1.01
-2.07
-1.65
-2.32
- -
Basic EPS from Cont Ops
-1.01
-2.07
-1.65
-2.32
- -
Diluted Weighted Avg Shares
127
74
137
151
- -
Diluted EPS, GAAP
-1.01
-2.07
-1.65
-2.32
- -
Diluted EPS from Cont Ops
-1.01
-2.07
-1.65
-2.32
- -

Balance Sheet (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Total Current Assets
87
391
578
906
1,007
+ Cash, Cash Equivalents & STI
80
384
566
892
991
+ Cash & Cash Equivalents
80
384
193
137
416
+ ST Investments
- -
- -
373
756
574
+ Accounts & Notes Receiv
- -
- -
1
2
5
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
1
2
5
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
8
7
12
12
11
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
34
55
111
112
236
+ Property, Plant & Equip, Net
27
49
52
49
46
+ Property, Plant & Equip
28
49
54
57
58
- Accumulated Depreciation
- -
- -
3
7
13
+ LT Investments & Receivables
- -
- -
52
58
185
+ LT Investments
- -
- -
52
58
185
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
6
6
7
5
5
+ Total Intangible Assets
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
6
6
7
5
5
Total Assets
121
445
689
1,018
1,243
+ Payables & Accruals
9
18
29
49
68
+ Accounts Payable
2
5
11
10
12
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
6
13
17
39
56
+ ST Debt
3
2
2
3
3
+ ST Borrowings
- -
- -
- -
- -
- -
+ ST Finance Leases
3
2
2
3
3
+ Other ST Liabilities
4
10
11
20
21
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
4
10
11
20
21
Total Current Liabilities
15
30
43
73
92
+ LT Debt
26
31
34
367
365
+ LT Borrowings
- -
- -
- -
335
337
+ LT Finance Leases
26
31
34
31
28
+ Other LT Liabilities
2
- -
34
57
112
+ Accrued Liabilities
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
2
- -
34
57
112
Total Noncurrent Liabilities
28
31
68
424
477
Total Liabilities
43
61
110
497
570
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
+ Share Capital & APIC
322
775
1,196
1,486
2,073
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
322
775
1,196
1,486
2,073
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
-244
-391
-616
-968
-1,401
+ Other Equity
- -
- -
-1
3
2
Equity Before Minority Interest
78
385
579
521
674
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
78
385
579
521
674
Total Liabilities & Equity
121
445
689
1,018
1,243
Shares Outstanding
127
127
148
157
181
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
28
33
37
34
31
Net Debt
-80
-384
-193
199
-79
Net Debt to Equity
-102.22
-99.77
-33.35
38.17
-11.73
Tangible Common Equity Ratio
64.42
86.36
84.01
51.21
54.19
Current Ratio
5.85
13.22
13.59
12.48
10.92
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
+ Net Income
-128
-152
-225
-352
-433
+ Depreciation & Amortization
- -
- -
3
5
6
+ Non-Cash Items
57
16
29
25
69
+ Stock-Based Compensation
8
11
24
39
69
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
49
6
5
-13
-1
+ Chg in Non-Cash Work Cap
- -
18
16
28
16
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-7
- -
-5
-1
-2
+ Inc (Dec) in Accts Payable
9
12
16
30
19
+ Inc (Dec) in Other
-1
6
5
-1
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-71
-118
-179
-293
-342
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-19
-11
-4
-4
+ Acq of Fixed Prod Assets
-1
-19
-11
-4
-4
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
60
- -
328
238
499
+ Increase in Capital Stock
60
- -
328
238
499
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-425
-385
78
+ Dec in LT Investment
- -
- -
- -
503
943
+ Inc in LT Investment
- -
- -
-425
-888
-865
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-19
-436
-389
74
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
335
- -
+ Cash From Debt
- -
- -
- -
335
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
441
95
50
50
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
60
441
424
623
549
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
-12
304
-191
-59
280
EBITDA
-83
-149
-217
-363
-442
EBITDA Margin (%)
- -
- -
- -
- -
- -
Free Cash Flow
-72
-137
-189
-297
-346
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-137
-189
38
-346
Free Cash Flow per Basic Share
-0.56
-1.86
-1.38
-1.96
- -
Price/Free Cash Flow
- -
-12.34
-26.35
-16.5
- -
Cash Flow to Net Income
0.55
0.77
0.79
0.83
0.79
Capital Expenditures
-1
-19
-11
-4
-4